Method for constructing libraries of non-standard peptide compounds comprising N-methyl amino acids and other special (non-standard) amino acids and method for searching and identifying active species
A method for screening a non-standard peptide compound in the peptide library that binds to the target substance, comprising the steps: (i) preparing a non-standard peptide library wherein a special (non-standard) amino acid is randomly incorporated into the peptide sequence by a cell-free (in vitro) translation system comprising a tRNA acylated by a special (non-standard) amino acid; (ii) bringing the obtained peptide library in contact with a target substance; and (iii) selecting a non-standard peptide that binds to the target substance as an active peptide.
1. A method for selecting a non-standard peptide comprising multiple N-methyl amino acids that specifically binds to a target substance from a peptide library, comprising the steps of:
(i) generating a peptide library by:
a) preparing a nucleic acid library comprising coding nucleic acids with each coding nucleic acid including a random sequence consisting of multiple different triplets, wherein at least one of the triplets in each of the random sequences correspond to artificial codons that specify N-methyl amino acids;
b) translating the nucleic acid library by an in vitro translation system wherein pairing of an anticodon of elongator tRNA acylated by a N-methyl amino acid and an artificial codon specifying the N-methyl amino acid occurs, and
c) thereby obtaining a peptide library of at least 10 13 types of peptides including non-standard peptides with randomly incorporated N-methyl amino acids, wherein each peptide in the peptide library and the coding nucleic acid are linked to form an in vitro display peptide library,
(ii) bringing the peptide library in contact with a target substance; and
(iii) selecting a non-standard peptide comprising multiple N-methyl amino acids that specifically binds to the target substance.
2. The method according to claim 1 , wherein step (iii) comprises recovering coding nucleic acids that display the selected peptides bound to the target substance, determining a nucleotide sequence of the coding nucleic acids, determining the peptide sequence from the nucleotide sequence, and selecting a non-standard peptide that specifically binds to the target substance comprising multiple N-methyl amino acids.
3. The method according to claim 1 , wherein the step (i) comprises acylating an elongator tRNA with a N-methyl amino acid using an RNA catalyst having an acyl-tRNA synthetase-like activity, to obtain an elongator tRNA acylated by the N-methyl amino acid.
4. The method according to claim 1 , wherein the elongator tRNA acylated by a N-methyl amino acid is an artificial tRNA prepared by an in vitro transcription.
5. The method according to claim 1 , wherein the nucleic acid library is a library of mRNAs.
6. The method according to claim 1 , wherein
each coding nucleic acid further includes sequences corresponding to
a codon specifying an amino acid having Functional Group 1, and
a codon specifying an amino acid having Functional Group 2, and
Functional Group 1 and Functional Group 2 are a pair of functional groups that are capable of bond forming reaction, and in the step (i), cyclic special peptides are included in the peptide library by a bond forming reaction between Functional Group 1 and Functional Group 2.
7. The method according to claim 1 , wherein each triplet constituting the random sequence is selected from codons having the following sequences:
an N 1 N 2 U codon {wherein N 1 and N 2 are independently one of A, U, C or G};
an N 1 N 2 K codon {wherein N 1 and N 2 are independently one of A, U, C or G, and K is either C or G};
an N 1 N 2 N 3 codon {wherein N 1 , N 2 and N 3 are independently one of A, U, C or G}.
8. The method according to claim 7 , wherein the random sequence consists of 2 or more repetitions of one of the N 1 N 2 U codon, the N 1 N 2 K codon and the N 1 N 2 N 3 codon.
9. The method according to claim 6 , wherein Functional Group 1 and Functional Group 2 are one of (A) to (C) below, which are pairs of functional groups:
(wherein, X 1 is either Cl or Br, and Ar is an aromatic ring that can comprise a substituent).
10. The method according to claim 6 , wherein the amino acid having Functional Group 1 is an amino acid having a chloroacetyl group and the amino acid having Functional Group 2 is cysteine.
11. The method according to claim 10 , wherein the each coding nucleic acid comprises (a) to (c) below:
(a) an initiator codon specifying an amino acid having a chloroacetyl group,
(b) a random sequence consisting of repetitions of an NNU {wherein, N is one ribonucleotide of A, U, C or G} codon, which comprises one or more artificial codons specifying N-methyl amino acids, and
(c) a codon specifying cysteine,
wherein the amino acid having a chloroacetyl group is incorporated in the N terminal of the peptide by pairing of the initiator codon and an anticodon of an initiator tRNA acylated by the amino acid having a chloroacetyl group,
and one or more N-methyl amino acids are incorporated in the peptide by pairing of each artificial codon specifying a N-methyl amino acid in the random sequence and an anticodon of an elongator tRNA acylated by a special the N-methyl amino acid, and the translation products, which are the peptides, are cyclized by a bond forming reaction between the chloroacetyl group and a sulfhydryl group of cysteine.
12. The method according to claim 1 , wherein the in vitro display peptide library is selected from a group consisting of ribosome display library, an mRNA display library, a RAPID display library, or a PD display library.